Brimonidine Tartrate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00484 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 14 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | papillary conjunctivitis | KG + DL |
| 2 | primary hereditary glaucoma | KG + DL |
| 3 | lichen disease | KG + DL |
| 4 | congenital hypotrichosis milia | KG + DL |
| 5 | rosacea conjunctivitis | KG + DL |
| 6 | hypotrichosis simplex of the scalp | KG + DL |
| 7 | diffuse alopecia areata | KG + DL |
| 8 | lichen planus pigmentosus | KG + DL |
| 9 | hypertrophic lichen planus | KG + DL |
| 10 | annular atrophic lichen planus | KG + DL |
| 11 | lichen planus pemphigoides | KG + DL |
| 12 | headache disorder | KG + DL |
| 13 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 14 | malformation syndrome with odontal and/or periodontal component | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.